Tower Research Capital (TRC)’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-3,437
Closed -$239K – 6138
2024
Q3
$239K Sell
3,437
-5,766
-63% -$395K 0.01% 1451
2024
Q2
$619K Buy
9,203
+8,745
+1,909% +$589K 0.01% 1153
2024
Q1
$31.6K Sell
458
-12,525
-96% -$845K ﹤0.01% 2607
2023
Q4
$808K Buy
12,983
+9,729
+299% +$544K 0.01% 1007
2023
Q3
$183K Buy
3,254
+1,428
+78% +$80.3K 0.01% 1495
2023
Q2
$92.2K Buy
1,826
+898
+97% +$47.8K ﹤0.01% 2080
2023
Q1
$50K Buy
928
+588
+173% +$34.4K ﹤0.01% 2504
2022
Q4
$21K Sell
340
-3,243
-91% -$215K ﹤0.01% 3111
2022
Q3
$253K Sell
3,583
-4,818
-57% -$332K ﹤0.01% 1690
2022
Q2
$476K Buy
8,401
+7,991
+1,949% +$438K 0.01% 1167
2022
Q1
$26K Sell
410
-146
-26% -$7.87K ﹤0.01% 3301
2021
Q4
$32K Sell
556
-3,812
-87% -$233K ﹤0.01% 3176
2021
Q3
$284K Sell
4,368
-1,737
-28% -$119K 0.01% 1466
2021
Q2
$387K Buy
6,105
+3,590
+143% +$212K 0.01% 1387
2021
Q1
$150K Buy
2,515
+1,197
+91% +$65.1K ﹤0.01% 2253
2020
Q4
$66K Sell
1,318
-11,903
-90% -$559K ﹤0.01% 2809
2020
Q3
$675K Buy
13,221
+10,994
+494% +$459K 0.01% 1355
2020
Q2
$78K Buy
+2,227
New +$76.7K ﹤0.01% 2680
2020
Q1
– Sell
-965
Closed -$27K – 4082
2019
Q4
$27K Buy
965
+69
+8% +$1.65K ﹤0.01% 1744
2019
Q3
$24K Buy
+896
New +$31.2K ﹤0.01% 2349
2019
Q1
– Sell
-3,639
Closed -$55K – 4386
2018
Q4
$55K Buy
+3,639
New +$54.2K ﹤0.01% 1237

Other funds holding AXNX

Tower Research Capital (TRC)'s AXNX Position: Q4 2024 in Review

Tower Research Capital (TRC) sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 3,437 shares — an estimated $239K sold.

Tower Research Capital (TRC) first reported a position in AXNX in Q4 2018 and held it in 21 quarters. The position peaked at $808K in Q4 2023. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

  • Tower Research Capital (TRC) reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 3,437 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $239K.
  • Tower Research Capital (TRC) first reported a position in Axonics, Inc. Common Stock in Q4 2018 and held it in 21 quarters.
  • Tower Research Capital (TRC)'s Axonics, Inc. Common Stock position peaked at $808K in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.